Gil Van Bokkelen has served as Athersys’ Chief Executive Officer and Chairman since 2000. Dr. Van Bokkelen co-founded Athersys in 1995 and has served as CEO and Director since the Company’s founding. Dr. Van Bokkelen is also the Chairman of the Board of Governors for the National Center for Regenerative Medicine, and serves on the boards of the BIO, (the Biotechnology Innovation Organization), and ARM, (the Alliance for Regenerative Medicine, where he previously also served as Chairman). Dr. Van Bokkelen has extensive business, operating, financial and scientific experience, and tremendous knowledge of the biotechnology industry. He received his Ph.D. in Genetics from Stanford University School of Medicine, his B.A. in Economics from the University of California at Berkeley, and also his B.A. in Molecular Biology from the University of California at Berkeley.